What is the current price and volume for OBSN.SW stock?

OBSN.SW stock trades pre-market at CHF 0.0012 with volume of 2,351,202 shares, about 3.48 times the average volume of 675,842 on the SIX exchange in Switzerland.

What does Meyka AI say about OBSN.SW stock?

Meyka AI rates OBSN.SW with a score out of 100: 58.59 (Grade C+, Suggestion: HOLD). The grade considers benchmarks, sector, metrics and forecasts; it is informational and not investment advice.

What are realistic price targets for OBSN.SW stock?

Our scenario targets: conservative CHF 0.0025, downside CHF 0.0008, and high-risk recovery CHF 0.0050. Targets reflect illiquidity, pipeline outcomes, and potential dilution.

What catalysts should traders watch for OBSN.SW stock?

Watch clinical trial readouts for linzagolix and ebopiprant, licensing announcements, and investor updates on cash runway; these items can trigger abrupt moves in the thinly traded stock.

CH Stocks

OBSN.SW ObsEva S.A. (SIX) pre-market at CHF 0.0012 on heavy volume: watch catalysts 03 Feb 2026

ByHuzaifa Zahoor February 3, 2026February 3, 2026

OBSN.SW stock opened the pre-market session at CHF 0.0012, down 76.92% from the previous close on unusually high turnover of 2,351,202 shares on the SIX Swiss Exchange. We see heavy intraday activity after the price hit a day high of CHF 0.0058 and a new day low at CHF 0.0012. ObsEva S.A. (OBSN.SW) is a small-cap Swiss biotech focused on women’s reproductive therapeutics, and today’s volume is nearly 3.48x the average daily volume of 675,842, marking it one of the most active names in the pre-market session. We outline the drivers, valuation, and what traders should watch next.